Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
This guide covers withdrawal-friendly total market ETFs and how to structure distributions to maximize cash flow while controlling taxes in retirement.
28,154 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
On-chain tokenized real-world assets approach $30 billion, but DeFi liquidity trails far behind, underscoring uneven ...
The first half of the year brought a sharp move for ServiceNow as AI expectations collided with reality. This article...
Meme coins linked to a president jumped on headlines about alien disclosure, led by the TRUMP token. The move faded a...
The U.S. debt machine is getting harder to stabilize as deficits rise and the Treasury market faces strain. Bitcoin i...
A new player in the chip foundry race is signaling aggressive pricing. If a potential rival wants undercut, investors...
Standard Chartered projects stablecoins could generate up to $1 trillion of new US Treasury demand by 2028, signaling...
Outpoll launches a global prediction market platform, bringing professional tools and API access to a mainstream audi...
Stock splits grab headlines, but the real question for investors is whether the move changes the investment case. Thi...
Rocket Companies closed 2025 with $6.7 billion in revenue and rising mortgage activity, alongside strategic deals tha...
The AI race is heating up, and anthropic (claude) only trillion is a headline that won’t fade. This article breaks do...
Texas Instruments preps for July earnings with a guidance-led breakout in industrial and data-center demand, plus a f...